Proteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factors.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Proteomics

• Publication date

  2017-05-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jprot.2017.03.022PMID 28363815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medulloblastoma initiation and spread: Where neurodevelopment, microenvironment and cancer cross pathways

  2016cited by this paper
• Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia

  2015cited by this paper
• LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression

  2015cited by this paper
• Disease implications of the Hippo/YAP pathway.

  2015cited by this paper
• SAHA regulates histone acetylation, Butyrylation, and protein expression in neuroblastoma.

  2014cited by this paper
• The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy

  2014cited by this paper
• Overexpression of YAP1 is Correlated with Progression, Metastasis and Poor Prognosis in Patients with Gastric Carcinoma

  2014cited by this paper
• Placental growth factor in cancer

  2014cited by this paper
• Childhood and adolescent cancer statistics, 2014

  2014cited by this paper
• DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway

  2014cited by this paper
• Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

  2013cited by this paper
• ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma

  2013cited by this paper
• Molecular Pathways Molecular Pathways : YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis

  2013cited by this paper
• Novel Gene Expression Model for Outcome Prediction in Paediatric Medulloblastoma

  2013cited by this paper
• A Fast Workflow for Identification and Quantification of Proteomes*

  2013cited by this paper
• How does cancer cell metabolism affect tumor migration and invasion?

  2013cited by this paper
• Medulloblastoma: recurrence and metastasis.

  2013cited by this paper
• Alterations in Cell-Extracellular Matrix Interactions during Progression of Cancers

  2012cited by this paper
• Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins

  2012cited by this paper
• Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: a Promising New Target for Metastatic Cancer

  2012cited by this paper
• Medulloblastomics: the end of the beginning

  2012cited by this paper
• The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain

  2012cited by this paper
• High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.

  2011cited by this paper
• SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.

  2011cited by this paper
• Andromeda: a peptide search engine integrated into the MaxQuant environment.

  2011cited by this paper
• Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

  2011cited by this paper
• Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.

  2011cited by this paper
• Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

  2011cited by this paper
• Proteomics Identification of ITGB3 as a Key Regulator in Reactive Oxygen Species-induced Migration and Invasion of Colorectal Cancer Cells*

  2011cited by this paper
• Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes.

  2011cited by this paper
• Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

  2010cited by this paper
• The hippo signaling pathway in development and cancer.

  2010cited by this paper
• The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.

  2010cited by this paper
• YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.

  2009cited by this paper
• Real-time single-molecule observation of rolling-circle DNA replication

  2009cited by this paper
• In-depth Qualitative and Quantitative Profiling of Tyrosine Phosphorylation Using a Combination of Phosphopeptide Immunoaffinity Purification and Stable Isotope Dimethyl Labeling*

  2009cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

  2008cited by this paper
• Signaling pathways in medulloblastoma

  2008cited by this paper
• Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation

  2008cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006cited by this paper
• THE ACTIN CYTOSKELETON AND METASTASIS

  2006cited by this paper
• Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies.

  2005cited by this paper
• The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

  2005cited by this paper
• Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

  2003cited by this paper
• Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

  2001cited by this paper
• Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

  1999cited by this paper
• Progelatinase A activation during tumor cell invasion.

  1994cited by this paper
• Progelatinase A activation during tumor cell invasion.

  1994cited by this paper
• Molecular and Cellular Pathobiology Functional Genomics Identifies Drivers of Medulloblastoma Dissemination

  year unknowncited by this paper

• Medulloblastoma: biology and immunotherapy

  2025cites this paper
• Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes.

  2025cites this paper
• Of travelling homeoproteins and medulloblastomas

  2025cites this paper
• Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review

  2021cites this paper
• A systematic view of pediatric medulloblastoma proteomics—current state of the field and future directions

  2021cites this paper
• LIM Homeobox Transcription Factors as Novel Prognosis Biomarkers in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells

  2019cites this paper
• Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth

  2019influential citation
• Medulloblastoma: optimizing care with a multidisciplinary approach

  2019cites this paper
• Pediatric brain tumors: Update of proteome-based studies.

  2018cites this paper